Table 2.

Dosage of liposomal amphotericin B received and apparent adverse events experienced during the 10-day treatment course among study cohort patients at Sadar District Hospital, Vaishali District, India (July 2007 to May 2008; N = 251)

Variables	N (%)
Number of doses received of liposomal amphotericin B
Two doses (10 mg/kg)	1 (0.4)
Three doses (15 mg/kg)	4 (1.6)
Four doses (20 mg/kg)	246 (98.0)
Apparent adverse event(s) experienced
No	129 (51.4)
Yes	122 (48.6)
Apparent adverse event experienced*
Muscle-skeletal system
Back pain	2 (0.8)
Digestive system
Nausea and vomiting	25 (10.0)
Diarrhea	20 (8.0)
Dyspepsia	12 (4.8)
Jaundice	2 (0.8)
Respiratory system
Upper respiratory infection†	39 (15.5)
Pneumonia	16 (6.4)
Coagulation system
Epistaxis	3 (1.2)
Skin and appendages
Rash	4 (1.6)
Urinary tract infection	4 (1.6)
Unspecified infections	6 (2.4)
Apparent adverse event during infusion
Chills/rigor	8 (3.2)
Severe lip swelling	3 (1.2)

^*One or more symptoms recorded for each patient.

^†Includes cough and sore throat only.